Programm                 "Degeneration und Regeneration– Grundlagen, Diagnostik und Therapie"


Hotelbuchung
   Hotel Registration
Grußwort
   Welcome address
Beteiligte Gesellschaften
   Societies involved
DOG Information
   DOG Information
Eröffnung des Kongresses
   Opening Ceremony
Preise
   Awards
Ablauf der Tagung 2003
   General overview of congress
Lageplan der Räumlichkeiten
   Map of Congress Center
Wissenschaftliche Themen
   Scientific topics
Symposien
   Symposia
Wissenschaftliches Programm
   Scientific program
Posterpräsentationen
   Poster Presentation
Kurse
   Courses
Begleitende Veranstaltungen
   Accompanying program
Arbeitssitzungen
   Working sessions
Rahmenprogramm
   Social program
Allgemeine Informationen
   General Information
Autorenindex
   Index of Authors
Industrieaussteller
   Commercial exhibitors
Sponsoren
   Sponsors
Impressum



DOG Homepage


Abstract
Abstract

Adiponectin – A New Candidate Antigen in Graves’ Ophthalmopathy (GO)?

Plicht M.1, Morgenthaler N.3, Steuhl K. P.1, Quadbeck B.2, Mann K.2, Esser J.1, Eckstein A.1
1Department of Ophthalmology, University Essen, 2Department of Medicine, Division of Endocrinology, University Essen, 3BRAHMS AG, Research, Biotechnology Centre Hennigsdorf/Berlin, Germany

Purpose: Adiponectin is a novel adipose tissue-specific protein. Synthesis and secretion of adiponectin is increased by the activation of the nuclear receptor PPARgamma. Recently a male type-2 diabetic, treated with the PPARgamma agonist Pioglitazone, experienced exacerbation of his GO. So we framed the hypothesis, that marked and lid swelling and proptosis, which are mainly caused by increased orbital adipose tissue, might be accompanied by increased adiponectin levels in GO.
Method: Adiponectin serum levels were evaluated in 166 GO patients in different activity (CASscore) and severity (NOSPECSscore) stages and in 25 normal controls. Patients had either activ GO = CAS > 2 or inactiv GO CAS Zurück | Back